Xie Q W, Cho H, Kashiwabara Y, Baum M, Weidner J R, Elliston K, Mumford R, Nathan C
Beatrice and Samuel A. Seaver Laboratory, Department of Medicine, Cornell University Medical College, New York, New York 10021.
J Biol Chem. 1994 Nov 11;269(45):28500-5.
Cloning of a nitric oxide synthase (NOS) from RAW 264.7 mouse macrophages (Xie, Q.-w., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and Nathan, C. (1992) Science 256, 225-228) yielded two sets of cDNA: one with a longer coding region of 1144 amino acids, whose sequence matched that of the purified protein, and another with a shorter coding region of 1122 amino acids, in which the last 10 carboxyl-terminal amino acids differed completely from those of the long form. We have now found that the short form lacks NOS activity. To determine the basis of this defect, we prepared recombinant chimeric, deletional, and point mutants of the long and short NOS variants, monitored their expression by immunoblot, and tested their enzymatic activity. By itself, lack of the 22-carboxyl-terminal residues of the long form NOS was scarcely consequential. Mutation of Phe1122, the only aromatic residue within one of the longest conserved regions shared by all NOSs of reported sequence, reduced enzymatic activity by 41%. Deletion of 23 carboxyl-terminal amino acids (including Phe1122) reduced activity by 71%. Further loss of Ile1121, another completely conserved residue, reduced activity by 95%, and with the deletion of the rest of the conserved region, NOS activity was undetectable. Normal dimerization and binding of heme and calmodulin by the short variants militated against distortions of tertiary structure affecting the amino-terminal half or middle portion of the protein. In contrast, the short variants were deficient in binding to NADPH, as predicted by a model of tertiary structure based on that of spinach ferredoxin-NADP+ reductase. This is the first demonstration that the carboxyl terminus of NOS is a functionally critical region.
从小鼠RAW 264.7巨噬细胞中克隆一氧化氮合酶(NOS)(谢启武、赵慧君、卡拉伊凯、芒福德、斯维德雷克、李泰德、丁爱、特罗索、内森(1992年)《科学》256卷,225 - 228页)得到了两组互补DNA:一组编码区较长,含1144个氨基酸,其序列与纯化蛋白的序列相符;另一组编码区较短,含1122个氨基酸,其羧基末端最后10个氨基酸与长型完全不同。我们现在发现短型缺乏NOS活性。为确定这种缺陷的原因,我们制备了长型和短型NOS变体的重组嵌合、缺失和点突变体,通过免疫印迹监测它们的表达,并测试它们的酶活性。就其本身而言,长型NOS缺失22个羧基末端残基几乎没有什么影响。苯丙氨酸1122(已报道序列的所有NOS共有的最长保守区域之一内唯一的芳香族残基)发生突变,酶活性降低了41%。缺失23个羧基末端氨基酸(包括苯丙氨酸1122)使活性降低了71%。另一个完全保守的残基异亮氨酸1121进一步缺失,使活性降低了95%,随着保守区域其余部分的缺失,无法检测到NOS活性。短变体正常的二聚化以及与血红素和钙调蛋白的结合排除了影响蛋白质氨基末端一半或中间部分的三级结构扭曲。相比之下,正如基于菠菜铁氧化还原蛋白 - NADP⁺还原酶三级结构的模型所预测的,短变体与NADPH的结合存在缺陷。这是首次证明NOS的羧基末端是一个功能关键区域。